Omnes Capital's investments

Sector 
Business services
Entry Date 
2016
Business 
Co-Investment

Global leading software editor for the simulation of sheet metal forming in the automotive industry
Headquartered in Switzerland, the company is the reference software editor for the simulation of sheet metal forming processes to the automotive industry.
Sector 
Pharma
Entry Date 
2016
Business 
Co-Investment

French pharmaceutical company specialized in complex generics
Headquartered in France with a global footprint, the company is specialised in the manufacturing and distribution of products with challenging formulations.
Sector 
Business services
Entry Date 
2014
Business 
Co-Investment

Leading environmental service provider in the Nordics
Headquartered in Finland, the company is a leading provider of business services in Sweden and Finland. With more than 650 employees and 33 facilities, the group provides three complementary services: industrial cleaning, demolition and waste treatment.
Sector 
Consumer goods
Entry Date 
2014
Business 
Co-Investment

Global leader in the market of high-end home audio
Headquartered in the United Sates, the company is one of the global leader on high-end home audio.
Sector 
Infrastructure
Entry Date 
2014
Business 
Renewable Energy

Villages Nature

13 MW geothermal heating network
The project is to build and operate a geothermal power plant that will supply a heating network providing hot water and heating to Euro Disney and a Pierre et Vacances holiday park. The plan is for the heating network to add further customers in the future (business parks, shopping centres). This is the Renewable Energy team’s first heating network. Omnes Capital acquired a 51% stake in this installation.
Sector 
Pharma
Entry Date 
2013
Business 
Venture Capital

Opsona Therapeutics

Novel therapeutic approaches to key targets of the innate immune system
Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease and atherosclerosis. The company was founded in 2004 by three world-renowned immunologists at Trinity College in Dublin.
Sector 
Medical devices
Entry Date 
2013
Business 
Venture Capital

Gecko Biomedical

Next-generation biodegradable adhesives for surgical sutures

Founded in 2013, Gecko Biomédical specialises in the development of innovative systems designed to close internal surgical wounds and specifically aims to meet the critical clinical need for sutures in mini-invasive surgery.
The company manufactures biodegradable and biocompatible elastic polymers in liquid film form and adhesive patches that can be adhered through light-activation by the surgeon, even in the presence of blood. Gecko Biomedical aims to employ its revolutionary products to complement or replace suture points when closing surgical wounds, currently one of the major challenges in medicine.

 

Sector 
Construction and building materials
Entry Date 
2013
Business 
Small-Cap Buyout & Growth Capital
Sales 
€80 million in 2014

HTI

Construction services

Organised into two business divisions (construction of telescopic access platforms and construction equipment, construction equipment rental), the HTI group offers a full range of services in its areas of expertise.

Sector 
SaaS / Cloud
Entry Date 
2013
Business 
Venture Capital

European Games Group

Video games company dedicated to independent developers without the financial clout to maximise their marketing efforts

The company specialises in monetising and marketing cross-platform video games that run on mobiles, tablets, Facebook or web browsers. The company has built up a substantial portfolio of games, including the highly popular Hero Zero by developer Playata. Hero Zero has signed up more than 17 million users and ranked as the eighth most searched-for game in Brazil during 2013, coming in ahead of AAA titles such as PES 2014.

Sector 
Infrastructure
Entry Date 
2013
Business 
Renewable Energy

Capenergie SGPS

Solar farm portfolio

Pages

NewsRoom
Publication
Omnes Newsletter no 32: VC news H2 2017
Press release
17 January 2018
VSORA closes series A financing with investment from
Omnes Capital, Partech Ventures, Angel Investors

Set to Launch Game-Changing Multicore DSP IP to Power 5G Wireless Networks

VSORA closes series A financing with investment from Omnes Capital, Partech Ventures, Angel Investors Set to Launch Game-Changing Multicore DSP IP to Power 5G Wireless Networks
Press release
16 January 2018
Batiweb Group announces buyout of Clien’tel.
The trading name “Le Bon Artisan” is to become “e-travaux”.

Batiweb Group announces buyout of Clien’tel. The trading name “Le Bon Artisan” is to become “e-travaux”.
Press release
05 January 2018
Enterome raises €32 million ($38.5 million) in a Series D financing
Enterome raises €32 million ($38.5 million) in a Series D financing
Publication
Omnes Newsletter no 32: small cap news H2 2017
Press release
04 January 2018
Themis Raises EUR 10 Million in Series C Financing to Advance Clinical
Pipeline
Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline
Press release
22 December 2017
ENGIE and Crédit Agricole Assurances increase their investments
in on-shore wind and solar power in France

ENGIE and Crédit Agricole Assurances increase their investments in on-shore wind and solar power in France

Pages